Published in Circ Res on November 25, 2005
The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol (2012) 6.07
Cardiac fibroblast: the renaissance cell. Circ Res (2009) 4.01
Targeting the tumour vasculature: insights from physiological angiogenesis. Nat Rev Cancer (2010) 2.93
Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation. Blood (2009) 2.73
The role of endothelial-to-mesenchymal transition in cancer progression. Br J Cancer (2008) 2.67
Coregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3. J Cell Biol (2006) 2.50
FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1. J Cell Biol (2009) 2.17
NOTCH3 expression is induced in mural cells through an autoregulatory loop that requires endothelial-expressed JAGGED1. Circ Res (2009) 2.15
VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling. Nat Cell Biol (2011) 2.09
Reactive gliosis and the multicellular response to CNS damage and disease. Neuron (2014) 2.08
Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism. Circ Res (2006) 2.08
Endothelial cell lumen and vascular guidance tunnel formation requires MT1-MMP-dependent proteolysis in 3-dimensional collagen matrices. Blood (2009) 2.04
Biomimetic hydrogels with pro-angiogenic properties. Biomaterials (2010) 1.98
Endothelial lumen signaling complexes control 3D matrix-specific tubulogenesis through interdependent Cdc42- and MT1-MMP-mediated events. Blood (2010) 1.98
Dense type I collagen matrices that support cellular remodeling and microfabrication for studies of tumor angiogenesis and vasculogenesis in vitro. Biomaterials (2010) 1.87
Endothelial-derived PDGF-BB and HB-EGF coordinately regulate pericyte recruitment during vasculogenic tube assembly and stabilization. Blood (2010) 1.81
Extracellular matrix-bound angiopoietin-like 4 inhibits endothelial cell adhesion, migration, and sprouting and alters actin cytoskeleton. Circ Res (2006) 1.73
In vitro assays of angiogenesis for assessment of angiogenic and anti-angiogenic agents. Microvasc Res (2007) 1.71
Adipose tissue extracellular matrix and vascular abnormalities in obesity and insulin resistance. J Clin Endocrinol Metab (2011) 1.65
Functional Human Vascular Network Generated in Photocrosslinkable Gelatin Methacrylate Hydrogels. Adv Funct Mater (2012) 1.63
Tumor-derived endothelial cells exhibit aberrant Rho-mediated mechanosensing and abnormal angiogenesis in vitro. Proc Natl Acad Sci U S A (2008) 1.60
Deletion of tetraspanin Cd151 results in decreased pathologic angiogenesis in vivo and in vitro. Blood (2006) 1.53
Recent insights into cerebral cavernous malformations: a complex jigsaw puzzle under construction. FEBS J (2010) 1.53
Caveolin-1-dependent beta1 integrin endocytosis is a critical regulator of fibronectin turnover. J Cell Sci (2008) 1.49
Mural cell associated VEGF is required for organotypic vessel formation. PLoS One (2009) 1.48
Formation of endothelial lumens requires a coordinated PKCepsilon-, Src-, Pak- and Raf-kinase-dependent signaling cascade downstream of Cdc42 activation. J Cell Sci (2009) 1.47
VEGF and FGF prime vascular tube morphogenesis and sprouting directed by hematopoietic stem cell cytokines. Blood (2011) 1.46
An essential role for SRC-activated STAT-3 in 14,15-EET-induced VEGF expression and angiogenesis. Blood (2008) 1.46
Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions. Biochim Biophys Acta (2009) 1.46
Extracellular matrix, inflammation, and the angiogenic response. Cardiovasc Res (2010) 1.45
Mesenchymal cells stimulate capillary morphogenesis via distinct proteolytic mechanisms. Exp Cell Res (2010) 1.43
Acute cutaneous wounds treated with human decellularised dermis show enhanced angiogenesis during healing. PLoS One (2015) 1.43
Genetic control of cell morphogenesis during Drosophila melanogaster cardiac tube formation. J Cell Biol (2008) 1.42
SPARC: a matricellular regulator of tumorigenesis. J Cell Commun Signal (2009) 1.41
Endothelial basement membrane limits tip cell formation by inducing Dll4/Notch signalling in vivo. EMBO Rep (2011) 1.40
Integrin-FAK signaling rapidly and potently promotes mitochondrial function through STAT3. Cell Commun Signal (2016) 1.38
Angiogenesis. Cold Spring Harb Perspect Biol (2011) 1.37
Modulation of human vascular endothelial cell behaviors by nanotopographic cues. Biomaterials (2010) 1.36
Experimental intrauterine growth restriction induces alterations in DNA methylation and gene expression in pancreatic islets of rats. J Biol Chem (2010) 1.36
Molecular basis for endothelial lumen formation and tubulogenesis during vasculogenesis and angiogenic sprouting. Int Rev Cell Mol Biol (2011) 1.36
Endothelial-mesenchymal transition and its contribution to the emergence of stem cell phenotype. Semin Cancer Biol (2012) 1.35
Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse. Dev Biol (2010) 1.34
Directed endothelial cell morphogenesis in micropatterned gelatin methacrylate hydrogels. Biomaterials (2012) 1.33
CCN2/connective tissue growth factor is essential for pericyte adhesion and endothelial basement membrane formation during angiogenesis. PLoS One (2012) 1.33
Integrin and growth factor receptor alliance in angiogenesis. Cell Biochem Biophys (2008) 1.31
Four-dimensional analysis of vascularization during primary development of an organ, the gonad. Proc Natl Acad Sci U S A (2008) 1.31
Surface characterization of extracellular matrix scaffolds. Biomaterials (2009) 1.28
The vasa vasorum in diseased and nondiseased arteries. Am J Physiol Heart Circ Physiol (2009) 1.28
The extracellular matrix and blood vessel formation: not just a scaffold. J Cell Mol Med (2007) 1.25
A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment. Integr Biol (Camb) (2011) 1.24
Vascular endothelial growth factor and substrate mechanics regulate in vitro tubulogenesis of endothelial progenitor cells. J Cell Mol Med (2010) 1.24
Arsenic stimulates sinusoidal endothelial cell capillarization and vessel remodeling in mouse liver. Hepatology (2007) 1.23
Topography of extracellular matrix mediates vascular morphogenesis and migration speeds in angiogenesis. PLoS Comput Biol (2009) 1.23
The Foxc2 transcription factor regulates angiogenesis via induction of integrin beta3 expression. J Biol Chem (2008) 1.22
Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling. Mol Cancer (2006) 1.22
Endothelial cell-pericyte interactions stimulate basement membrane matrix assembly: influence on vascular tube remodeling, maturation, and stabilization. Microsc Microanal (2011) 1.20
Molecular mechanisms controlling vascular lumen formation in three-dimensional extracellular matrices. Cells Tissues Organs (2011) 1.19
Protein kinase C-epsilon regulates sphingosine 1-phosphate-mediated migration of human lung endothelial cells through activation of phospholipase D2, protein kinase C-zeta, and Rac1. J Biol Chem (2008) 1.19
Integrin affinity modulation in angiogenesis. Cell Cycle (2007) 1.17
Selective induction of integrin beta1 by hypoxia-inducible factor: implications for wound healing. FASEB J (2008) 1.17
Angiopoietin-1/Tie2 signal augments basal Notch signal controlling vascular quiescence by inducing delta-like 4 expression through AKT-mediated activation of beta-catenin. J Biol Chem (2011) 1.14
Altered fibroblast proteoglycan production in COPD. Respir Res (2010) 1.14
Fibers in the extracellular matrix enable long-range stress transmission between cells. Biophys J (2013) 1.14
EGFL7 meets miRNA-126: an angiogenesis alliance. J Angiogenes Res (2010) 1.12
Extraction and assembly of tissue-derived gels for cell culture and tissue engineering. Tissue Eng Part C Methods (2009) 1.09
A hybrid model for three-dimensional simulations of sprouting angiogenesis. Biophys J (2008) 1.09
Matricryptic sites control tissue injury responses in the cardiovascular system: relationships to pattern recognition receptor regulated events. J Mol Cell Cardiol (2009) 1.08
A key role for the integrin alpha2beta1 in experimental and developmental angiogenesis. Am J Pathol (2009) 1.07
Imaging and quantifying the dynamics of tumor-associated proteolysis. Clin Exp Metastasis (2008) 1.07
The aortic ring model of angiogenesis: a quarter century of search and discovery. J Cell Mol Med (2009) 1.07
ADAMTS9 is a cell-autonomously acting, anti-angiogenic metalloprotease expressed by microvascular endothelial cells. Am J Pathol (2010) 1.07
SPARC-induced increase in glioma matrix and decrease in vascularity are associated with reduced VEGF expression and secretion. Int J Cancer (2008) 1.06
Microfluidic technology in vascular research. J Biomed Biotechnol (2009) 1.06
Differential gene expression in a coculture model of angiogenesis reveals modulation of select pathways and a role for Notch signaling. Physiol Genomics (2008) 1.05
Matrix metalloproteinase 2-integrin alpha(v)beta3 binding is required for mesenchymal cell invasive activity but not epithelial locomotion: a computational time-lapse study. Mol Biol Cell (2008) 1.05
Membrane type-1 matrix metalloproteinase potentiates basic fibroblast growth factor-induced corneal neovascularization. Am J Pathol (2009) 1.03
NG2 proteoglycan promotes tumor vascularization via integrin-dependent effects on pericyte function. Angiogenesis (2013) 1.03
Fibroblast growth factor receptor-1 signaling in pancreatic islet beta-cells is modulated by the extracellular matrix. Mol Endocrinol (2007) 1.03
Spatial control of cell-mediated degradation to regulate vasculogenesis and angiogenesis in hyaluronan hydrogels. Biomaterials (2012) 1.02
In vivo laser speckle imaging reveals microvascular remodeling and hemodynamic changes during wound healing angiogenesis. Angiogenesis (2011) 1.02
Collagen oligomers modulate physical and biological properties of three-dimensional self-assembled matrices. Biopolymers (2010) 1.02
Low level arsenic promotes progressive inflammatory angiogenesis and liver blood vessel remodeling in mice. Toxicol Appl Pharmacol (2006) 1.02
Fibrin encapsulation and vascular endothelial growth factor delivery promotes ovarian graft survival in mice. Tissue Eng Part A (2011) 1.02
Glycosaminoglycan-based hydrogels to modulate heterocellular communication in in vitro angiogenesis models. Sci Rep (2014) 1.01
Matrix-Bound VEGF Mimetic Peptides: Design and Endothelial Cell Activation in Collagen Scaffolds. Adv Funct Mater (2011) 1.01
Targeting cardiac fibroblasts to treat fibrosis of the heart: focus on HDACs. J Mol Cell Cardiol (2014) 1.00
Hypoxia-inducible hydrogels. Nat Commun (2014) 1.00
Non-destructive label-free monitoring of collagen gel remodeling using optical coherence tomography. Biomaterials (2010) 0.99
Cyclin-dependent kinase inhibitors block leukocyte adhesion and migration. J Immunol (2008) 0.99
Molecular mediators of angiogenesis. J Burn Care Res (2010) 0.98
Mechanical strain activates a program of genes functionally involved in paracrine signaling of angiogenesis. Physiol Genomics (2008) 0.97
The CXC-chemokine CXCL4 interacts with integrins implicated in angiogenesis. PLoS One (2008) 0.97
The relative importance of topography and RGD ligand density for endothelial cell adhesion. PLoS One (2011) 0.97
The role of autophagy in vascular biology. Circ Res (2015) 0.96
Microvascular maturity elicited in tissue treated with cytokine-loaded hyaluronan-based hydrogels. Biomaterials (2008) 0.96
Proangiogenic role of ephrinB1/EphB1 in basic fibroblast growth factor-induced corneal angiogenesis. Am J Pathol (2007) 0.96
Lipid phosphate phosphatase 3 stabilization of beta-catenin induces endothelial cell migration and formation of branching point structures. Mol Cell Biol (2010) 0.96
The extracellular matrix is a novel attribute of endothelial progenitors and of hypoxic mature endothelial cells. FASEB J (2012) 0.95
Early embryonic vascular patterning by matrix-mediated paracrine signalling: a mathematical model study. PLoS One (2011) 0.95
VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins. FASEB J (2004) 2.27
Orphan nuclear receptor TR3/Nur77 regulates VEGF-A-induced angiogenesis through its transcriptional activity. J Exp Med (2006) 1.80
Rho activity critically and selectively regulates endothelial cell organization during angiogenesis. Proc Natl Acad Sci U S A (2004) 1.67
Molecular profiling of angiogenesis markers. Am J Pathol (2002) 1.57
Active Rac1 improves pathologic VEGF neovessel architecture and reduces vascular leak: mechanistic similarities with angiopoietin-1. Blood (2010) 1.56
Extracellular matrix mediates a molecular balance between vascular morphogenesis and regression. Curr Opin Hematol (2008) 1.39
Collagen I initiates endothelial cell morphogenesis by inducing actin polymerization through suppression of cyclic AMP and protein kinase A. J Biol Chem (2002) 1.36
Matrix-specific activation of Src and Rho initiates capillary morphogenesis of endothelial cells. FASEB J (2004) 1.23
Moderation of calpain activity promotes neovascular integration and lumen formation during VEGF-induced pathological angiogenesis. PLoS One (2010) 1.11
Calpain inhibitors reduce retinal hypoxia in ischemic retinopathy by improving neovascular architecture and functional perfusion. Biochim Biophys Acta (2010) 1.03
In vivo and in vitro models of Mammalian angiogenesis. Methods Mol Biol (2005) 1.02
Cdc42-mediated inhibition of GSK-3β improves angio-architecture and lumen formation during VEGF-driven pathological angiogenesis. Microvasc Res (2010) 0.97
Functional overlap and cooperativity among alphav and beta1 integrin subfamilies during skin angiogenesis. J Invest Dermatol (2003) 0.87
VEGF-A, cytoskeletal dynamics, and the pathological vascular phenotype. Exp Cell Res (2005) 0.86
Moderate GSK-3β inhibition improves neovascular architecture, reduces vascular leakage, and reduces retinal hypoxia in a model of ischemic retinopathy. Angiogenesis (2010) 0.84